Score Overview
See the full market ranking โ
Allarity Therapeutics Inc fundamental performance
Across Allarity Therapeutics Inc's full reported history, from 2021 to 2025, revenue grew from $ 0.00 to $ 320K and net income went from -$ 26M to -$ 11M. Revenue increased in 25% of the years measured; net income in 75%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.40 | โ |
1 Year2025-08-12 | $ 0.96 | 45.85% |
All Time2021-12-21 | $ 1000K | -100.00% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | All Time2021-12-21 |
|---|---|---|---|
| Price | $ 1.40 | $ 0.96 | $ 1000K |
| Return | โ | 45.85% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 320K | -$ 11M | $ 14M |
| 2024 | $ 0.00 | -$ 24M | $ 19M |
| 2023 | $ 0.00 | -$ 11M | $ 166K |
| 2022 | $ 0.00 | -$ 16M | $ 2M |
| IPO2021 | $ 0.00 | -$ 26M | $ 19M |
Explore beyond ALLR
You're looking at Allarity Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.